On September 29, 2009
AZ Loses $13M Zoladex Appeal in “Do the Math!” Case
AstraZeneca lost a federal appeals court ruling and must pay $13 million in damages for manipulating the price of prostate cancer drug Zoladex. The case involved an AZ campaign to persuade doctors to over-bill the government for Zoladex. It urged, “DO THE MATH!” in letters that explained how using Zoladex was more profitable for docs than other cancer drugs.
0 Comments